U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H23ClN10
Molecular Weight 510.981
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N<sup>2</sup>-(2-Chloro-4-pyrimidinyl)-N<sup>2</sup>,N<sup>4</sup>-bis(2,3-dimethyl-2H-indazol-6-yl)-2,4-pyrimidinediamine

SMILES

CN1N=C2C=C(NC3=NC(=NC=C3)N(C4=CC5=NN(C)C(C)=C5C=C4)C6=NC(Cl)=NC=C6)C=CC2=C1C

InChI

InChIKey=GRNJBSNDQPAOEF-UHFFFAOYSA-N
InChI=1S/C26H23ClN10/c1-15-19-7-5-17(13-21(19)33-35(15)3)30-23-9-11-29-26(31-23)37(24-10-12-28-25(27)32-24)18-6-8-20-16(2)36(4)34-22(20)14-18/h5-14H,1-4H3,(H,29,30,31)

HIDE SMILES / InChI

Approval Year

Name Type Language
N<sup>2</sup>-(2-Chloro-4-pyrimidinyl)-N<sup>2</sup>,N<sup>4</sup>-bis(2,3-dimethyl-2H-indazol-6-yl)-2,4-pyrimidinediamine
Common Name English
Pazopanib Related Compound 2
Common Name English
2,4-Pyrimidinediamine, N<sup>2</sup>-(2-chloro-4-pyrimidinyl)-N<sup>2</sup>,N<sup>4</sup>-bis(2,3-dimethyl-2H-indazol-6-yl)-
Systematic Name English
Code System Code Type Description
FDA UNII
7BP9RHC4LP
Created by admin on Sat Dec 16 19:47:59 GMT 2023 , Edited by admin on Sat Dec 16 19:47:59 GMT 2023
PRIMARY
CAS
1226500-02-2
Created by admin on Sat Dec 16 19:47:59 GMT 2023 , Edited by admin on Sat Dec 16 19:47:59 GMT 2023
PRIMARY